ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

AAA Biotech Announces High-Quality Recombinant Proteins Portfolio to Further Develop Research in Life Sciences





AAA Biotech added more recombinant proteins to their catalog to broaden the scope of biomedical research. Available with custom solutions and worldwide delivery.

LA JOLLA, CA, August 12, 2025 /24-7PressRelease/ -- With a collection of over 600 recombinant antibodies, AAA Biotech is the global leader in providing the highest quality research reagents.

The company announces more additions of rProteins to expand its product line to enhance biomedical research in life sciences.

Recombinant Proteins to Meet the Needs of the Experiment

AAA Biotech is aiming to provide recombinant proteins worldwide to meet the astronomical arrays of applications and biological targets that researchers strive to achieve in their experiments.

Research in modern life sciences uses recombinant proteins as tools created by specific, controlled genetic engineering methods, where the target genes are expressed in an active system, e.g., E. coli, mammalian cells (HEK293, CHO), yeast, and insect cells for various purposes.

NOTE: The recombinant protein product delivered by the company is strictly controlled in terms of its quality, such as purities usually more than 95% by means of the validated affinity chromatography procedures, and is available in all sorts of formats (such as being multiple tagged (His, GST, FLAG, Fc fusion) to allow simple purification and detection).

Features of Recombinant Proteins Delivered by AAA Biotech

Major features of rProteins provided by AAA Biotech that stand out are:

High Purity & Activity: The Majority of proteins are guaranteed 95% pure, with bioactivity forms being specifically tested.

Various Expression Systems: Proteins can be expressed in a variety of systems, prokaryotic (E. coli), eukaryotic (HEK293, CHO, yeast, insect), to suit folding, post-translational modification, and/or functionality.

Flexible Use: Best suited to scrutinize protein-protein and protein-DNA interactions, assess functional biological assays, standard ELISA curves, drug discovery, including validation of biomarkers and analysis of immune signaling.

Custom Variants: Flexibility Options in custom expressions and tags are available to meet the requirements of experiments.

Tight QC & Documentation: Selected products are tested and analyzed by SDS-PAGE, endotoxin, and, where available, activity assays and Certificates of Analysis on a per-batch basis.

Friendly Formats: Proteins are available in lyophilized or ready-to-use liquid form, which is friendly in storage and handling.

About AAA Biotech

AAA Biotech, Inc. is a trusted provider of high-quality research reagents worldwide. Founded by enthusiastic scientists with a mission to provide the best scientific reagents.

With specialization in providing validated antibodies, ELISA kits, PCR kits, and rProteins, the company has a strong commitment to scientific excellence by supporting researchers in academia and life sciences.

For more information about AAA Biotech's validated antibodies and other research reagents, visit the company's official website: https://www.aaabiotech.com/.

Tel: +1 (619) 604-9440
Fax: +1 (619) 604-9441
Toll Free: +1-800-604-9114

Email: info@aaabiotech.com
Tech Support: tech@aaabiotech.com

Mailing Address:
AAA Biotech, LLC
PO Box 1697
La Jolla, CA 92038



---
Press release service and press release distribution provided by https://www.24-7pressrelease.com
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.